Protein A immunoadsorption in alloimmunized patients refractory to platelet transfusions and in patients with treatment-resistant immune thrombocytopoenic purpura

Transfusion Science

Volumn 19, Issue SUPPL., 1997, Pages 47-52

  Gutensohn, K ^a   Zander, A R ^a   Rowley, S D ^b   Hester, J ^c   Kuehnl, P ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b USA   (United States)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN A;

ALLOIMMUNIZATION; CELL DESTRUCTION; CONFERENCE PAPER; FEMALE; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; IMMUNOADSORPTION; PLASMA VOLUME; REMISSION; THROMBOCYTE COUNT; THROMBOCYTE TRANSFUSION;

EID: 0031950629     PISSN: 09553886     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0955-3886(97)00103-3     Document Type: Conference Paper

References (18)

1. Kelton JG, Gibbons S: Autoimmune platelet destruction: idiopathic thrombocytopenic purpura. Semin Thromb Hemost 1982; 8:83-89.
2. George JN, El-Harake MA, Raskob GE: Chronic idiopathic thrombocytopenic purpura. N Engl J Med 1994; 3:1207-1211.
3. Fincher JK: Quantitative platelet disorders, in Lotspeich-Steininger CA, Stiene-Martin EA, Koepke JA (eds.): Clinical Hematology. Philadelphia, J.B. Lippincott, 1992, pp. 680-688.
4. Sniecinski I, O'Donnell, MR: Prevention of refractoriness and HLA-alloimmunization using filtered blood products. Blood 1988; 71:1402-1407.
5. Kickler TS: The platelet transfusion refractory state: transfusion practices and clinical management, in Kurtz SR, Brubaker DB (eds): Clinical Decisions in Platelet Therapy. Bethseda, American Association of Blood Banks, 1992, pp. 87-104.
6. Christie DJ, Howe RB, Lennon SS, Sauro SC: Treatment of refractoriness to platelet transfusion therapy by protein A column therapy. Transfusion 1993; 33:234-242.
7. Klein CA, Blajchman MA: Alloantibodies and platelet destruction. Semin Thromb Hemost 1982; 8:105-109.
8. Samuelsson G: Extracorporeal immunoadsorption with Immunosorba protein A, in Agishi T (ed.): Therapeutic Plasmapheresis, 1993, pp. 843-845.
9. Rosse WF, Adams JP, Yount WJ: Subclasses of IgG antibodies in immune thrombocytopenic purpura (ITP). Br J Haematol 1980; 46:109-114.
10. Howe RB, Christie DJ: Protein A immunoadsorption treatment in hematology: an overview. J Clin Apheresis 1994; 9:31-32.
11. Kim HC, Dugan NP, Snyder HW, Bunin N: Protein A-immunoadsorption treatment in children with refractoriness to platelet transfusion (RPT). Blood 1992; 80:222a.
12. Lopez-Plaza I, Miller K, Leitman SF: Ineffectiveness of protein A adsorption in the treatment of platelet refractoriness. J Clin Apheresis 1992; 7:33.
13. Snyder HW, Cochran SK, Balint JP, et al.: Experience with protein A-immunoadsorprtion in treatment-resistant adult immune thrombocytopenic purpura. Blood 1992; 79:2237-2245.
14. Drew MJ: Resolution of refractory, classic thrombotic thrombocytopenic purpura after staphylococcal protein A immunoadsorption. Transfusion 1994; 34:536-538.
15. Krsnak J: Immunoadsorption column treatment for refractory ITP. ANNA Journal 1994; 21:198-199.
16. Balint JP, Snyder HW, Cochran SK, Jones FR: Long-term response of immune thrombocytopenia to extracorporeal immunoadsorption. Lancet 1991; 337:1106.
17. Guthrie TH, Oral A: Immune thrombocytopenia purpura: a pilot study of staphylococcal protein A immunomodulation in refractory patients. Semin Hematol 1989; 26:3-9.
18. Löliger C, Rühlmann E, Kühnl P: A rapid and sensitive immunoassay for antibodies against alloantigens on human platelet glycoproteins (BIPA). J Immunol Meth 1993; 158:197-200.